These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31534732)

  • 1. Amplification and attenuation of lung metastases depending on glucocorticoid dosage implicating long-acting activated memory cells induced by nivolumab against malignant melanoma.
    Katagiri K; Shiga K; Saito D; Oikawa SI; Ikeda A; Tsuchida K; Miyaguchi J
    Clin Case Rep; 2019 Sep; 7(9):1709-1713. PubMed ID: 31534732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma patient response to nivolumab treatment for metastatic lung lesions: Multi-OMICS analysis in Project HOPE.
    Kiyohara Y; Yoshikawa S; Otsuka M; Kondou R; Iizuka A; Nonomura C; Ohshima K; Urakami K; Kusuhara M; Nagashima T; Sugino T; Yamaguchi K; Akiyama Y
    J Dermatol; 2017 Oct; 44(10):1156-1159. PubMed ID: 28452169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of central/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibody.
    Yamaguchi K; Mishima K; Ohmura H; Hanamura F; Ito M; Nakano M; Tsuchihashi K; Ota SI; Wada N; Uchi H; Ariyama H; Kusaba H; Niiro H; Akashi K; Baba E
    Cancer Sci; 2018 Oct; 109(10):3032-3042. PubMed ID: 30066977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence and early onset of nivolumab-induced pneumonitis: four case reports and literature review.
    Koyama N; Iwase O; Nakashima E; Kishida K; Kondo T; Watanabe Y; Takahashi H; Umebayashi Y; Ogawa Y; Miura H
    BMC Pulm Med; 2018 Jan; 18(1):23. PubMed ID: 29378571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A first reported case of metastatic anorectal amelanotic melanoma with a marked response to anti-PD-1 antibody nivolumab: A case report.
    Tokuhara K; Nakatani K; Tanimura H; Yoshioka K; Kiyohara T; Kon M
    Int J Surg Case Rep; 2017; 31():188-192. PubMed ID: 28171845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma.
    Bottlaender L; Breton AL; de Laforcade L; Dijoud F; Thomas L; Dalle S
    J Immunother Cancer; 2017 Jul; 5(1):57. PubMed ID: 28716106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of long-term survival treated with three metastasectomies and two subsequent adjuvant nivolumab therapies for recurrent malignant melanoma of the esophagus.
    Hanada K; Tsunoda S; Nomura M; Fujimura S; Yutaka Y; Nishigori T; Hisamori S; Maekewa H; Hoshino N; Itami A; Tanaka E; Obama K
    Surg Case Rep; 2022 Nov; 8(1):206. PubMed ID: 36333558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Benefits of Ipilimumab among Japanese Patients with Nivolumab-Refractory Mucosal Melanoma: A Case Series Study.
    Saijo K; Imai H; Ouchi K; Okada Y; Sato Y; Komine K; Takahashi M; Takahashi S; Shirota H; Takahashi M; Ishioka C
    Tohoku J Exp Med; 2019 May; 248(1):37-43. PubMed ID: 31105123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of interferon-beta and nivolumab in oral mucosal melanoma.
    Fusumae T; Kamiya K; Chiang B; Okada H; Nakano N; Maekawa T; Komine M; Murata S; Ohtsuki M
    J Dermatol; 2018 Jan; 45(1):87-90. PubMed ID: 28944501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiologic features of pneumonitis associated with nivolumab in non-small-cell lung cancer and malignant melanoma.
    Baba T; Sakai F; Kato T; Kusumoto M; Kenmotsu H; Sugiura H; Tominaga J; Oikado K; Sata M; Endo M; Yanagawa N; Sasaki S; Iwasawa T; Saito Y; Fujiwara Y; Ohe Y; Yamazaki N; Sakamoto T; Koshiba T; Kuwano K
    Future Oncol; 2019 Jun; 15(16):1911-1920. PubMed ID: 31020849
    [No Abstract]   [Full Text] [Related]  

  • 11. Nivolumab to pembrolizumab switch induced a durable melanoma response: A case report.
    Lepir T; Zaghouani M; Roche SP; Li YY; Suarez M; Irias MJ; Savaraj N
    Medicine (Baltimore); 2019 Jan; 98(2):e13804. PubMed ID: 30633154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nivolumab induced pulmonary sarcoid-like granulomas with a concurrent pleural schwannoma: A pathologic-radiologic correlation of a rare condition mimicking metastatic melanoma.
    Jain PV; Squires C; Gasparri M; Sheinin Y
    Ann Diagn Pathol; 2022 Apr; 57():151880. PubMed ID: 34972037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete remission in metastatic primary malignant melanoma of the esophagus with nivolumab: a case report.
    Okamoto T; Nakano E; Yamauchi T
    J Med Case Rep; 2021 Jul; 15(1):345. PubMed ID: 34256852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitiligo-like Depigmentation in a Patient Undergoing Treatment with Nivolumab for Advanced Renal-cell Carcinoma.
    Navarro-Fernandez I; Gonzalez-Vela C; Gomez-Fernandez C; Duran-Vian C; Reguero L; Gonzalez-Lopez M
    Acta Dermatovenerol Croat; 2021 Apr; 291(1):54-55. PubMed ID: 34477066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of primary malignant melanoma of the esophagogastric junction with abscopal effect after nivolumab administration.
    Yamaguchi T; Fushida S; Kinoshita J; Saito H; Shimada M; Terai S; Moriyama H; Okamoto K; Nakamura K; Ninomiya I; Inaki N
    Surg Case Rep; 2021 Dec; 7(1):253. PubMed ID: 34882298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine level predicts the therapeutic effect of anti-PD-1 antibody (nivolumab) therapy for malignant melanoma.
    Nakamura K; Ashida A; Kiniwa Y; Okuyama R
    Arch Dermatol Res; 2022 Nov; 314(9):887-895. PubMed ID: 34842960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus: A case report.
    Inadomi K; Kumagai H; Arita S; Tsuruta N; Takayoshi K; Mishima K; Ota SI; Tanaka M; Okumura Y; Sagara K; Nio K; Nakano M; Uchi H; Yamamoto H; Ariyama H; Kusaba H; Niiro H; Oda Y; Akashi K; Baba E
    Medicine (Baltimore); 2016 Jul; 95(29):e4283. PubMed ID: 27442668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse alveolar hemorrhage with pseudoprogression during nivolumab therapy in a patient with malignant melanoma.
    Ikeda T; Yamaguchi H; Dotsu Y; Taniguchi H; Gyoutoku H; Senju H; Sakamoto N; Iwanaga S; Kuwatsuka Y; Fukuda M; Mukae H
    Thorac Cancer; 2018 Nov; 9(11):1522-1524. PubMed ID: 30253076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary malignant melanoma of the esophagus successfully treated with nivolumab: a case report.
    Ito S; Tachimori Y; Terado Y; Sakon R; Narita K; Goto M
    J Med Case Rep; 2021 May; 15(1):237. PubMed ID: 33947459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nivolumab in metastatic melanoma: good efficacy and tolerability in elderly patients.
    De Luca R; Meraviglia S; Blasi L; Maiorana A; Cicero G
    Curr Oncol; 2020 Apr; 27(2):e75-e80. PubMed ID: 32489255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.